Back

Discussion.

29 August 2022 (13:32 - 13:45)
Organised by:
Congress Presentation Part of: SGLT-2 inhibitors - Another piece of the puzzle in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) Open Access ESC Congress 2022

5 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
SGLT2 inhibitors across the spectrum of heart failure.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Practical considerations for treating HF with mildly reduced and preserved EF.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Implementing best practices across the spectrum of heart failure.
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Summary.
Slides Video

Access the full session

Session thumbnail
SGLT-2 inhibitors - Another piece of the puzzle in heart failure
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 13:32 CET
You may be interested in
thumbnail
Congress Presentation
A broader benefit: from heart failure to wider cardio-renal-metabolic (CRM) conditions
31 August 2024
thumbnail
Congress Presentation
How do SGLT2 inhibitors act in heart failure? – discussion.
26 August 2022
thumbnail
Congress Presentation
SGLT2 inhibitors and heart failure: mechanisms and clinical implications
30 August 2025
thumbnail
Congress Presentation
Updates on current heart failure treatment - discussion
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources